What is the initial treatment for vitamin B12 deficiency when serum vitamin B12 is less than 150 pmol/L?

Initial Treatment of Vitamin B12 Deficiency (B12 <150 pmol/L)

For vitamin B12 levels less than 150 pmol/L (confirmed deficiency), immediately initiate hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks if there are no neurological symptoms, followed by lifelong maintenance therapy of 1 mg intramuscularly every 2-3 months. 1

Critical First Step: Assess for Neurological Involvement

Before initiating treatment, you must determine whether neurological symptoms are present, as this fundamentally changes the treatment regimen:

Neurological symptoms to evaluate:

• Unexplained sensory symptoms (paresthesias, numbness)
• Motor symptoms (weakness, gait disturbance, ataxia)
• Cognitive changes or psychiatric symptoms
• Peripheral neuropathy

If ANY neurological involvement is present or suspected:

• Seek urgent specialist advice from neurology and hematology 1
• Administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs
• Then continue with 1 mg intramuscularly every 2 months for maintenance 1

Treatment Algorithm Based on Clinical Presentation

Without Neurological Symptoms (Most Common)

• Loading phase: Hydroxocobalamin 1 mg IM three times weekly for 2 weeks 1
• Maintenance: Hydroxocobalamin 1 mg IM every 2-3 months lifelong 1

With Neurological Symptoms (Urgent)

• Intensive loading: Hydroxocobalamin 1 mg IM on alternate days until no further improvement 1
• Maintenance: Hydroxocobalamin 1 mg IM every 2 months 1

Critical Safety Consideration

Do NOT give folic acid before or simultaneously with initial B12 treatment. Folic acid can mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord, causing irreversible neurological damage. 1 Always treat B12 deficiency first, then address any concurrent folate deficiency after B12 repletion has begun.

Route of Administration Considerations

While the 2020 British Obesity and Metabolic Surgery Society guidelines (which reference NICE recommendations) strongly favor intramuscular therapy as first-line [1-1], recent evidence suggests oral high-dose B12 (1-2 mg daily) can be effective for most patients without severe manifestations 2, 3. However, intramuscular administration remains the gold standard for:

• Confirmed B12 <150 pmol/L (definite deficiency)
• Any neurological involvement
• Severe anemia or hematological manifestations
• Malabsorption syndromes (including post-bariatric surgery, pernicious anemia, inflammatory bowel disease)
• When rapid correction is essential

The intramuscular route ensures reliable absorption independent of gastrointestinal function and leads to more rapid improvement in severe cases 2.

Common Pitfalls to Avoid

1. Delaying treatment while awaiting additional testing: With B12 <150 pmol/L, deficiency is confirmed. Start treatment immediately—do not wait for methylmalonic acid or homocysteine results [1-1]

2. Using oral supplementation as first-line in severe deficiency: While oral therapy may work for mild dietary deficiency, B12 <150 pmol/L warrants parenteral therapy initially [1-1,2]

3. Inadequate loading phase: The intensive 2-week loading regimen (3x weekly) is essential for replenishing depleted stores—don't skip directly to maintenance dosing [1-1]

4. Forgetting lifelong maintenance: B12 deficiency typically requires indefinite treatment, especially when caused by malabsorption rather than dietary insufficiency [1-1]

5. Missing concurrent nutritional deficiencies: Check and correct folate, iron, and other micronutrient deficiencies after initiating B12 treatment [1-1]

Monitoring Response

Expect hematological improvement within days to weeks, with reticulocytosis typically occurring within 3-5 days. Neurological recovery is slower and may be incomplete if treatment is delayed. The presence of macrocytosis or hypersegmented neutrophils supports the diagnosis but their absence does not exclude B12 deficiency 4, 3.